Search

Remy Brim Phones & Addresses

  • Arlington, VA
  • 2001 16Th St NW APT 704, Washington, DC 20009 (202) 483-5196
  • Ann Arbor, MI
  • Farmington Hills, MI
  • 5005 Campus Hill Dr, Okemos, MI 48864 (517) 347-9959
  • Livonia, MI
  • East Lansing, MI

Work

Company: Senator elizabeth warren Apr 2013 Address: Washington D.C. Metro Area Position: Legislative assistant

Education

Degree: PhD School / High School: University of Michigan 2006 to 2011 Specialities: Pharmacology

Skills

Public Speaking • Pharmacology • Grant Writing • Policy Analysis • Policy • Research • Event Planning • Microsoft Office • Health Policy • Fda • Legislation • Microbiology • Clinical Trials • Healthcare • Medical Ethics • Cell Culture • Molecular Biology • Legislative Affairs • Tissue Culture • Protein Purification • Protein Chemistry • Confocal Microscopy • Cell Biology • Political Strategy • Health Care Reform • Medicare/Medicaid Reimbursement

Interests

Health Care Policy • Clinical Trials • Regulatory Affairs • Drug Development • Bioethics • Fda • Medicare

Industries

Legislative Office

Resumes

Resumes

Remy Brim Photo 1

Vice President Regulatory Policy And Strategy

View page
Location:
8000 Maryland Ave, Clayton, MO 63105
Industry:
Legislative Office
Work:
Senator Elizabeth Warren - Washington D.C. Metro Area since Apr 2013
Legislative Assistant

U.S. House of Representatives - Office of Congresswoman Allyson Schwartz May 2012 - Apr 2013
Health Care Policy Fellow

National Institutes of Health - Bethesda, MD Sep 2011 - Apr 2013
Bioethics Fellow

University of Michigan - Ann Arbor, MI Sep 2006 - Aug 2011
Graduate Student Research Assistant

Michigan State University - East Lansing, MI Sep 2003 - May 2006
Undergraduate Research Assitant
Education:
University of Michigan 2006 - 2011
PhD, Pharmacology
Michigan State University 2003 - 2006
B.S., Microbiology and Molecular Genetics
Skills:
Public Speaking
Pharmacology
Grant Writing
Policy Analysis
Policy
Research
Event Planning
Microsoft Office
Health Policy
Fda
Legislation
Microbiology
Clinical Trials
Healthcare
Medical Ethics
Cell Culture
Molecular Biology
Legislative Affairs
Tissue Culture
Protein Purification
Protein Chemistry
Confocal Microscopy
Cell Biology
Political Strategy
Health Care Reform
Medicare/Medicaid Reimbursement
Interests:
Health Care Policy
Clinical Trials
Regulatory Affairs
Drug Development
Bioethics
Fda
Medicare

Publications

Us Patents

Thermostabilization Of Proteins

View page
US Patent:
20110142816, Jun 16, 2011
Filed:
Jul 10, 2008
Appl. No.:
12/667895
Inventors:
Donald W. Landry - New York NY, US
James H. Woods - Ann Arbor MI, US
Roger K. Sunahara - Ann Arbor MI, US
Diwahar L. Narasimhan - Ann Arbor MI, US
Joanne MacDonald - New York NY, US
Milan N. Stojanovich - Fort Lee NJ, US
John J. Tesmer - Ann Arbor MI, US
Remy L. Brim - Farmington Hills MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 38/46
C12N 9/96
C12Q 1/44
A61K 31/7088
C07H 21/00
A61P 25/30
US Classification:
424 946, 435188, 435 19, 514 44 R, 536 232
Abstract:
Provided are compositions comprising a cocaine esterase (CocE) and a compound that thermostabilizes the CocE. Also provided are methods of thermostabilizing a cocaine esterase. Additionally provided are methods of treating a mammal under-going a cocaine-induced condition. Methods of determining whether a compound is a thermostabilizing agent for a protein are also provided. Uses of the above-described compositions for the treatment of a cocaine-induced condition is additionally provided. Additionally provided is an isolated nucleic acid encoding a CocE polypeptide having the substitutions L169K and G173Q, and the CocE polypeptide encoded by that nucleic acid, and pharmaceutical compositions thereof. Further provided is the use of that composition for the manufacture of a medicament for the treatment of a cocaine-induced condition and for the treatment of a cocaine-induced condition.

Thermostabilization Of Proteins

View page
US Patent:
20170106056, Apr 20, 2017
Filed:
Dec 25, 2016
Appl. No.:
15/390514
Inventors:
Donald W. Landry - New York NY, US
James H. Woods - Ann Arbor MI, US
Roger K. Sunahara - Ann Arbor MI, US
Diwahar L. Narasimhan - Ann Arbor MI, US
Joanne MacDonald - New York NY, US
Milan N. Stojanovic - Fort Lee NJ, US
John J. Tesmer - Ann Arbor MI, US
Remy L. Brim - Farmington Hills MI, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 38/46
C12N 9/18
C12Q 1/44
A61K 9/00
Abstract:
Provided are compositions comprising a cocaine esterase (CocE) and a compound that thermostabilizes the CocE. Also provided are methods of thermostabilizing a cocaine esterase. Additionally provided are methods of treating a mammal undergoing a cocaine-induced condition. Methods of determining whether a compound is a thermostabilizing agent for a protein are also provided. Uses of the above-described compositions for the treatment of a cocaine-induced condition is additionally provided. Additionally provided is an isolated nucleic acid encoding a CocE polypeptide having the substitutions L169K and G173Q, and the CocE polypeptide encoded by that nucleic acid, and pharmaceutical compositions thereof. Further provided is the use of that composition for the manufacture of a medicament for the treatment of a cocaine-induced condition and for the treatment of a cocaine-induced condition.

Thermostabilization Of Proteins

View page
US Patent:
20140348813, Nov 27, 2014
Filed:
Jan 28, 2014
Appl. No.:
14/166619
Inventors:
Donald W. Landry - New York NY, US
James H. Woods - Ann Arbor MI, US
Roger K. Sunahara - Ann Arbor MI, US
Diwahar L. Narasimhan - Ann Arbor MI, US
Joanne MacDonald - New York NY, US
Milan N. Stojanovich - Fort Lee NJ, US
John J. Tesmer - Ann Arbor MI, US
Remy L. Brim - Farmington Hills MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K 47/22
C12Q 1/44
A61K 47/18
A61K 38/46
A61K 47/12
US Classification:
424 946, 435 19, 506 11
Abstract:
Provided are compositions comprising a cocaine esterase (CocE) and a compound that thermostabilizes the CocE. Also provided are methods of thermostabilizing a cocaine esterase. Additionally provided are methods of treating a mammal undergoing a cocaine-induced condition. Methods of determining whether a compound is a thermostabilizing agent for a protein are also provided. Uses of the above-described compositions for the treatment of a cocaine-induced condition is additionally provided. Additionally provided is an isolated nucleic acid encoding a CocE polypeptide having the substitutions L169K and G173Q, and the CocE polypeptide encoded by that nucleic acid, and pharmaceutical compositions thereof. Further provided is the use of that composition for the manufacture of a medicament for the treatment of a cocaine-induced condition and for the treatment of a cocaine-induced condition.
Remy L Brim from Arlington, VA, age ~38 Get Report